Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SENSE: HX575 epoetin alfa in CKD anemia
NCT01576341Phase 3Completed
- Sponsor
- Sandoz
- Start
- Apr 2012
- Primary completion
- Oct 2014
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 7
01
Overview
A Phase 3 trial of epoetin alfa in anemia of chronic kidney disease (CKD-A), sponsored by Sandoz. Started Apr 2012; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01576341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576341.